Literature DB >> 18332083

ATF5 is a highly abundant liver-enriched transcription factor that cooperates with constitutive androstane receptor in the transactivation of CYP2B6: implications in hepatic stress responses.

Maya Pascual1, M José Gómez-Lechón, José V Castell, Ramiro Jover.   

Abstract

Activating transcription factor (ATF) 5 is a member of the ATF/cAMP response element-binding protein family, which has been associated with differentiation, proliferation, and survival in several tissues and cell types. However, its role in the liver has not yet been investigated. We show herein that ATF5 is a highly abundant liver-enriched transcription factor (LETF) whose expression declines in correlation with the level of dedifferentiation in cultured human hepatocytes and cell lines. Re-expression of ATF5 in human HepG2 cells by adenoviral transduction resulted in a marked selective up-regulation of CYP2B6. Moreover, adenoviral cotransfection of ATF5 and constitutive androstane receptor (CAR) caused an additive increase in CYP2B6 mRNA. These results were confirmed in cultured human hepatocytes, where the cooperation of ATF5 and CAR not only increased CYP2B6 basal expression but also enhanced the induced levels after phenobarbital or 6-(4-chloropheny-l)-imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime (CITCO). Comparative sequence analysis of ATF5 and ATF4, its closest homolog, showed a large conservation of the mRNA 5'-untranslated region organization, suggesting that ATF5 might be up-regulated by stress responses through a very similar translational mechanism. To investigate this possibility, we induced endoplasmic reticulum stress by means of amino acid limitation or selective chemicals, and assessed the time course response of ATF5 and CYP2B6. We found a post-transcriptional up-regulation of ATF5 and a parallel induction of CYP2B6 mRNA. Our findings uncover a new LETF coupled to the differentiated hepatic phenotype that cooperates with CAR in the regulation of drug-metabolizing CYP2B6 in the liver. Moreover, ATF5 and its target gene CYP2B6 are induced under different stress conditions, suggesting a new potential mechanism to adapt hepatic cytochrome P450 expression to diverse endobiotic/xenobiotic harmful stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18332083     DOI: 10.1124/dmd.107.019380

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  29 in total

1.  BCL-2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in a cell type-dependent manner.

Authors:  Douglas Dluzen; Guangfu Li; Diana Tacelosky; Matthew Moreau; David X Liu
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

2.  CCAAT/enhancer-binding protein alpha (C/EBPalpha) and hepatocyte nuclear factor 4alpha (HNF4alpha) synergistically cooperate with constitutive androstane receptor to transactivate the human cytochrome P450 2B6 (CYP2B6) gene: application to the development of a metabolically competent human hepatic cell model.

Authors:  Marta Benet; Agustín Lahoz; Carla Guzmán; José V Castell; Ramiro Jover
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

3.  Expression patterns of activating transcription factor 5 (atf5a and atf5b) in zebrafish.

Authors:  Roberto Rodríguez-Morales; Viveca Vélez-Negrón; Aranza Torrado-Tapias; Gaurav Varshney; Martine Behra
Journal:  Gene Expr Patterns       Date:  2020-07-11       Impact factor: 1.224

Review 4.  Integrating the UPRmt into the mitochondrial maintenance network.

Authors:  Christopher J Fiorese; Cole M Haynes
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-02-22       Impact factor: 8.250

5.  Deletion of Scap in alveolar type II cells influences lung lipid homeostasis and identifies a compensatory role for pulmonary lipofibroblasts.

Authors:  Valérie Besnard; Susan E Wert; Mildred T Stahlman; Anthony D Postle; Yan Xu; Machiko Ikegami; Jeffrey A Whitsett
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

6.  Gene expression profiling and network analysis reveals lipid and steroid metabolism to be the most favored by TNFalpha in HepG2 cells.

Authors:  Amit K Pandey; Neha Munjal; Malabika Datta
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

7.  Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland.

Authors:  Simone Mitterhuemer; Wolfram Petzl; Stefan Krebs; Daniel Mehne; Andrea Klanner; Eckhard Wolf; Holm Zerbe; Helmut Blum
Journal:  BMC Genomics       Date:  2010-02-25       Impact factor: 3.969

8.  Hepatic heme-regulated inhibitor (HRI) eukaryotic initiation factor 2alpha kinase: a protagonist of heme-mediated translational control of CYP2B enzymes and a modulator of basal endoplasmic reticulum stress tone.

Authors:  Poulomi Acharya; Jane-Jane Chen; Maria Almira Correia
Journal:  Mol Pharmacol       Date:  2010-01-13       Impact factor: 4.436

Review 9.  The transcription factor ATF5: role in neurodevelopment and neural tumors.

Authors:  Lloyd A Greene; Hae Young Lee; James M Angelastro
Journal:  J Neurochem       Date:  2008-11-15       Impact factor: 5.372

10.  Identification of a novel DNA binding site and a transcriptional target for activating transcription factor 5 in c6 glioma and mcf-7 breast cancer cells.

Authors:  Guangfu Li; Wenhong Li; James M Angelastro; Lloyd A Greene; David X Liu
Journal:  Mol Cancer Res       Date:  2009-06-16       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.